A few reports concerning pegylated interferon-α (PEG-IFN-α)-based combination treatment in elderly chronic hepatitis C (CHC) patients have been published, with slightly different treatment outcomes. The gene discussed is IFNA1; the disease is chronic hepatitis C virus infection.